What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3)
AUTOR(ES)
Peen, Elisabeth
FONTE
BioMed Central
RESUMO
Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti-proteinase 3 (PR3) antibody contained many negatively charged aspartic acid residues, perhaps contributing to its reactivity with positively charged PR3 regions. Examination of four other human monoclonal anti-PR3 antibodies shows a number of negatively charged residues within their CDR3 regions. Mapping of segments of linear PR3-epitopes reacting with anti-neutrophil cytoplasmic antibodies (ANCA) demonstrated a preliminary estimate of structures contributing to antigenic determinants. T-cell epitopes on PR3 are reported in studies of chronic myeloid leukemia. These T-cell epitopes appear to be human leukocyte antigen (HLA) A2.1 restricted.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=130014Documentos Relacionados
- What you should know about PR3-ANCA: Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA
- What you should know about PR3-ANCA: An introduction
- What you should know about PR3-ANCA: Evidence for the role of T cells in the pathogenesis of systemic vasculitis
- Book Reviews: Hypoglycemia: Fact or Fad?—What You Should Know About Low Blood Sugar
- What you need to know about acute ataxias in adults
